Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Virbac SA

VRBCFPNK
Healthcare
Drug Manufacturers - General
$346.00
$-85.80(-19.87%)
U.S. Market opens in 8h 24m

Virbac SA Fundamental Analysis

Virbac SA (VRBCF) shows moderate financial fundamentals with a PE ratio of 18.49, profit margin of 9.29%, and ROE of 12.62%. The company generates $1.4B in annual revenue with strong year-over-year growth of 12.07%.

Key Strengths

PEG Ratio-2.61
Current Ratio1.96

Areas of Concern

Cash Position4.77%
We analyze VRBCF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 73.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
73.4/100

We analyze VRBCF's fundamental strength across five key dimensions:

Efficiency Score

Weak

VRBCF struggles to generate sufficient returns from assets.

ROA > 10%
7.33%

Valuation Score

Excellent

VRBCF trades at attractive valuation levels.

PE < 25
18.49
PEG Ratio < 2
-2.61

Growth Score

Excellent

VRBCF delivers strong and consistent growth momentum.

Revenue Growth > 5%
12.07%
EPS Growth > 10%
20.42%

Financial Health Score

Excellent

VRBCF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.31
Current Ratio > 1
1.96

Profitability Score

Weak

VRBCF struggles to sustain strong margins.

ROE > 15%
12.62%
Net Margin ≥ 15%
9.29%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VRBCF Expensive or Cheap?

P/E Ratio

VRBCF trades at 18.49 times earnings. This indicates a fair valuation.

18.49

PEG Ratio

When adjusting for growth, VRBCF's PEG of -2.61 indicates potential undervaluation.

-2.61

Price to Book

The market values Virbac SA at 2.31 times its book value. This may indicate undervaluation.

2.31

EV/EBITDA

Enterprise value stands at 8.59 times EBITDA. This is generally considered low.

8.59

How Well Does VRBCF Make Money?

Net Profit Margin

For every $100 in sales, Virbac SA keeps $9.29 as profit after all expenses.

9.29%

Operating Margin

Core operations generate 17.54 in profit for every $100 in revenue, before interest and taxes.

17.54%

ROE

Management delivers $12.62 in profit for every $100 of shareholder equity.

12.62%

ROA

Virbac SA generates $7.33 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.33%

Following the Money - Real Cash Generation

Operating Cash Flow

Virbac SA produces operating cash flow of $195.15M, showing steady but balanced cash generation.

$195.15M

Free Cash Flow

Virbac SA produces free cash flow of $87.44M, offering steady but limited capital for shareholder returns and expansion.

$87.44M

FCF Per Share

Each share generates $10.44 in free cash annually.

$10.44

FCF Yield

VRBCF converts 3.56% of its market value into free cash.

3.56%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

18.49

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.61

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.31

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.72

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.31

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.96

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.13

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.18

vs 25 benchmark

How VRBCF Stacks Against Its Sector Peers

MetricVRBCF ValueSector AveragePerformance
P/E Ratio18.4929.28 Better (Cheaper)
ROE12.62%820.00% Weak
Net Margin9.29%-19731.00% (disorted) Weak
Debt/Equity0.310.26 Neutral
Current Ratio1.964.69 Neutral
ROA7.33%-17993.00% (disorted) Weak

VRBCF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Virbac SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

49.86%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

183.62%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

56.15%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ